Study Finds Clinical Worries over DTC Tests in Europe | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A majority of clinical geneticists in Europe are concerned that genetic tests marketed directly to consumers are not clinically useful, and a large percentage believe that sales of certain types of DTC tests should be more closely regulated or banned, according to a study presented today at the European Society of Human Genetics conference in Amsterdam.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.